A new trading day began on June 22, 2022, with Ikena Oncology Inc. (NASDAQ: IKNA) stock priced at $3.36, up 5.48% from the previous day of trading. During the day, the shares moved up to $3.7999 and dropped to $3.22 before settling in for the closing price of $3.47. IKNA’s price has ranged from $2.83 to $17.60 over the past 52 weeks.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free.
Sponsored
Meanwhile, its annual earnings per share averaged 4.70%. With a float of $36.02 million, this company’s outstanding shares have now reached $36.08 million.
Let’s look at the performance matrix of the company that is accounted for 67 employees.
Ikena Oncology Inc. (IKNA) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Ikena Oncology Inc. is 0.40%, while institutional ownership is 93.71%. The most recent insider transaction that took place on Jan 11, was worth 11,568. In this transaction Chief Scientific Officer of this company sold 964 shares at a rate of $12.00, taking the stock ownership to the 44,475 shares. Before that another transaction happened on Jan 10, when Company’s Chief Scientific Officer sold 36 for $12.00, making the entire transaction worth $432. This insider now owns 44,475 shares in total.
Ikena Oncology Inc. (IKNA) Latest Financial update
In its latest quarterly report, released on 3/30/2022, the company reported earnings of -$0.47 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). This company achieved a net margin of -110.10 while generating a return on equity of -63.87. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.43 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 4.70% per share during the next fiscal year.
Ikena Oncology Inc. (NASDAQ: IKNA) Trading Performance Indicators
Here are Ikena Oncology Inc.’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 8.50. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.02.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.15, a number that is poised to hit -0.49 in the next quarter and is forecasted to reach -1.62 in one year’s time.
Technical Analysis of Ikena Oncology Inc. (IKNA)
Ikena Oncology Inc. (NASDAQ: IKNA) saw its 5-day average volume 0.63 million, a positive change from its year-to-date volume of 0.18 million. As of the previous 9 days, the stock’s Stochastic %D was 19.06%. Additionally, its Average True Range was 0.50.
During the past 100 days, Ikena Oncology Inc.’s (IKNA) raw stochastic average was set at 9.26%, which indicates a significant decrease from 23.66% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 138.96% in the past 14 days, which was higher than the 128.75% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.38, while its 200-day Moving Average is $9.51. Nevertheless, the first resistance level for the watch stands at $3.90 in the near term. At $4.14, the stock is likely to face the second major resistance level. The third major resistance level sits at $4.48. If the price goes on to break the first support level at $3.32, it is likely to go to the next support level at $2.98. The third support level lies at $2.74 if the price breaches the second support level.
Ikena Oncology Inc. (NASDAQ: IKNA) Key Stats
With a market capitalization of 124.29 million, the company has a total of 36,163K Shares Outstanding. Currently, annual sales are 30,990 K while annual income is -34,120 K. The company’s previous quarter sales were 3,380 K while its latest quarter income was -16,840 K.
